Skip to main content
CRONEX.CO.,LTD logo

CRONEX.CO.,LTD — Investor Relations & Filings

Ticker · 215570 ISIN · KR7215570003 KO Professional, scientific and technical activities
Filings indexed 177 across all filing types
Latest filing 2022-05-02 Capital/Financing Update
Country KR South Korea
Listing KO 215570

About CRONEX.CO.,LTD

http://www.cronex.co.kr/

CRONEX.CO.,LTD. is a Contract Research Organization (CRO) that provides research and development services for the pharmaceutical and biomaterial industries. The company focuses on the supply and manufacture of biological species and bio-tissue materials for medical research. Its key offerings include non-clinical CRO services centered on the use of minipigs, particularly for xenograft research and development. The company also engages in the development of medicines and raw materials, and provides services related to transgenic technologies.

Recent filings

Filing Released Lang Actions
전환사채(해외전환사채포함)발행후만기전사채취득(제1회차)
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from a Korean company (Cronex) detailing the acquisition of convertible bonds before their maturity date. This type of corporate action, specifically related to the company's debt and capital structure changes, falls under the category of Capital/Financing Update (CAP).
2022-05-02 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a shareholder meeting (주주총회소집 결의) issued by the company 'Cronex'. It details the date, time, location, and the agenda items (appointment of outside directors and auditors). This type of document is sent to shareholders to provide information and request votes for an upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2022-04-07 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (임시주주총회). It does not contain the full proxy materials or the meeting results, but rather serves as a formal notice of a corporate action (setting a record date). Given the nature of the announcement and the lack of a specific category for 'Record Date Notice', it falls under the general regulatory filing category.
2022-04-07 Korean
[기재정정]사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (정정신고) for a previously filed 'Business Report' (사업보고서), which is the Korean equivalent of an Annual Report (10-K). It details specific corrections made to financial statements, executive information, and subsidiary details. Since it is a formal correction to an existing Annual Report and contains substantive financial data and disclosures, it is classified as an Annual Report (10-K). FY 2021
2022-03-29 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회 결과' (Annual General Meeting Results) and details the outcomes of the shareholder meeting held on 2022-03-29, including the approval of financial statements, dividend decisions, and board-related resolutions. This falls directly under the definition of a Declaration of Voting Results & Voting Rights Announcement.
2022-03-29 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is titled '감사보고서 제출' (Submission of Audit Report) and provides a summary of the audit opinion, key financial data, and the name of the accounting firm. While it contains financial data, it is a formal notification of the submission of the audit report to the regulatory body, rather than the full annual report or a standalone audit report document itself. Following the 'Menu vs Meal' rule, this is a report publication announcement. FY 2021
2022-03-21 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.